MCO | Earnings Review — Q2 2026

MCO's Q2'26 is a broad, simultaneous acceleration: total revenue of $2,185M grew +15.1% YoY — the fastest of the trailing 10 quarters — and beat consensus of $2,087M by +4.7%. Adjusted diluted EPS of $4.68 grew +31.5% YoY and beat the Street's $4.26 by +9.9%, the widest beat since FY2024Q4 and a sharp reversal of four straight quarters of narrowing surprise magnitude (down to just +2.6% at Q1'26). Consolidated adjusted operating margin expanded +440bps YoY to 55.3% (source) — the largest margin gain in the window — so EPS growth outpaced revenue growth by roughly 2x on pure operating leverage. The engine is ratings issuance: MIS revenue +26.0% YoY ($1,260M), Corporate Finance +27.1% YoY ($651M), on more than $2 trillion of debt rated for a second consecutive quarter. The one soft spot: Moody's Analytics revenue growth slowed to +4.2% YoY ($925M), its weakest print in the 10-quarter window, even as MA's own margin kept expanding (+150bps YoY) and ARR held ~9% growth.

Guidance was not banked to match the beat. FY2026 adjusted EPS guide moved only to $16.50–$17.00 (mid $16.75), +0.3% vs. the prior guide midpoint and actually -0.9% below current consensus ($16.90) — despite a +31.5% YoY EPS quarter. CFO Noemie Heuland framed the entire beat explicitly as a pull-forward: "a record June issuance pulled that activity forward" from an expected Q3 recovery, and "at the halfway point of the year, we're sitting where our full year plan always expected us to be." Consistent with that framing, revenue and MA ARR guidance (high-single-digit, unchanged) were left alone; what did move was capital return — buybacks raised to up to $3.0B (from ~$2.5B) and the restructuring envelope expanded by $100M through YE2027 — while free cash flow guidance was actually cut $100M to $2.7-$2.9B on working capital/restructuring costs. Guidance math implies a sharp H2 step-down: H1'26 actual EPS of $9.01 vs. FY guide mid of $16.75 leaves only ~$7.74 of implied H2 EPS (+2.4% YoY) — and at the guide's low end, implied H2 EPS growth is negative.

Tone: confident, no hedged bear case offered this quarter ("standout second quarter," "exceptional... results") — a shift from Q1'26's scenario-driven, tariff-hedged framing. But the Street pushed back hard on the H2 revenue guide's conservatism live on the call, and management's defense leaned on the 2025 playbook (guided down post-tariff-shock, recovered almost exactly to plan) rather than new demand data.

Contradictions (2 found): local_facts.md misstates the FY2026 MCO adjusted operating margin guide floor as 52% vs. the Q4'25 call's actual 50%-53% range — a 2-point gap on the same guidance metric. Separately, the Q1'26 and Q2'26 transcripts contain a verbatim-identical KYC "grew 13%... deeper penetration" sentence — implausible for two independently-computed YoY figures three months apart, and flagged as a likely transcript data-duplication error rather than a real business contradiction.

Catalysts into Q3'26 (reports Oct 28, 2026): the Q3 print itself (consensus EPS $4.27, +8.9% YoY implied — faster than the H2 guide math can support, meaning either Q4 estimates are too high or the guide has more cushion than the raise suggests); FOMC meetings in September and October (rate-cut/hike split); the hyperscaler/AI debt wave (issuance already above MCO's full-year forecast, but bond order-book coverage has been softening); and new MA CEO Christina Kosmowski's early turnaround moves.

| Quarter | Total Revenue | Rev YoY% | Adj. Op. Margin | YoY bps | MIS Revenue | MIS YoY% | MA Revenue | MA YoY% | Adjusted EPS | EPS YoY% | |---|---|---|---|---|---|---|---|---|---|---| | 2024Q1 | $1,786M | — | 50.7% | — | $979M | — | $799M | — | $3.37 | — | | 2024Q2 | $1,817M | — | 49.6% | — | $1,005M | — | $802M | — | $3.28 | — | | 2024Q3 | $1,813M | — | 47.8% | — | $974M | — | $831M | — | $3.21 | — | | 2024Q4 | $1,672M | — | 43.8% | — | $801M | — | $863M | — | $2.62 | — | | 2025Q1 | $1,924M | +7.7% | 51.7% | +100bps | $1,056M | +7.9% | $859M | +7.5% | $3.83 | +13.6% | | 2025Q2 | $1,898M | +4.5% | 50.9% | +130bps | $1,000M | -0.5% | $888M | +10.7% | $3.56 | +8.5% | | 2025Q3 | $2,007M | +10.7% | 52.9% | +510bps | $1,091M | +12.0% | $909M | +9.4% | $3.92 | +22.1% | | 2025Q4 | $1,889M | +13.0% | 48.7% | +490bps | $937M | +17.0% | $943M | +9.3% | $3.64 | +38.9% | | 2026Q1 | $2,079M | +8.1% | 53.2% | +150bps | $1,140M | +8.0% | $926M | +7.8% | $4.33 | +13.1% | | 2026Q2 | $2,185M | +15.1% | 55.3% | +440bps | $1,260M | +26.0% | $925M | +4.2% | $4.68 | +31.5% |

5-year annual (FY2021-FY2025):

| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Total revenue | $6,218M | $5,468M | $5,916M | $7,088M | $7,718M | | Revenue YoY% | — | -12.1% | +8.2% | +19.8% | +8.9% | | Adj. operating margin | 49.9% | 42.6% | 43.9% | 48.1% | 51.1% | | Adjusted diluted EPS | $12.29 | $8.57 | $9.90 | $12.47 | $14.94 | | Adjusted EPS YoY% | — | -30.3% | +15.5% | +26.0% | +19.8% |

xychart-beta
    title "MCO Quarterly Revenue & Adjusted Operating Income ($M) — 24Q1-26Q2"
    x-axis [24Q1, 24Q2, 24Q3, 24Q4, 25Q1, 25Q2, 25Q3, 25Q4, 26Q1, 26Q2]
    y-axis "$ Millions" 600 --> 2300
    bar [1786, 1817, 1813, 1672, 1924, 1898, 2007, 1889, 2079, 2185]
    line [906, 902, 867, 733, 994, 966, 1062, 920, 1105, 1208]

Verdict — accelerating, broadly. Revenue growth stepped up from +8.1% (Q1'26) to +15.1% (Q2'26), margin expanded the most in the window, and EPS growth hit its second-best print (+31.5%, behind only Q4'25's comp-flattered +38.9%). MIS/ratings issuance is the driver; MA's revenue deceleration to +4.2% YoY — its softest of the window even as MA margin keeps expanding — is the trend to watch into Q3'26.

| Quarter | EPS Est. | EPS Actual | Surprise | Result | |---|---|---|---|---| | 2024Q3 (10-22-24) | $2.86 | $3.21 | +12.2% | 🟢 Beat | | 2024Q4 (02-13-25) | $2.27 | $2.62 | +15.4% | 🟢 Beat | | 2025Q1 (04-22-25) | $3.54 | $3.83 | +8.2% | 🟢 Beat | | 2025Q2 (07-23-25) | $3.39 | $3.56 | +5.0% | 🟢 Beat | | 2025Q3 (10-22-25) | $3.70 | $3.92 | +5.9% | 🟢 Beat | | 2025Q4 (02-18-26) | $3.43 | $3.64 | +6.1% | 🟢 Beat | | 2026Q1 (04-22-26) | $4.22 | $4.33 | +2.6% | 🟢 Beat | | ▶ 2026Q2 (07-22-26) — THIS QTR | $4.26 | $4.68 | +9.9% | 🟢 Beat |

Revenue beat: $2,185M actual vs. $2,087M consensus, +4.7%.

| Window | EPS beat rate | |---|---| | L12Q (FY2023Q4-FY2026Q2) | 11/12 = 91.7% (lone miss: FY2023Q4, -5.6%) | | L4Q (FY2025Q3-FY2026Q2) | 4/4 = 100% |

Pattern: a consistent beater, currently on a 10-consecutive-quarter EPS beat streak (FY2024Q1 through FY2026Q2). Surprise magnitude had been steadily narrowing — from a peak of +15.4% (FY2024Q4) down to +2.6% at FY2026Q1, the tightest beat in the window — before this quarter reversed that pattern sharply back to +9.9%, the largest beat since FY2024Q3/Q4. Per management's own framing this looks like a timing pull-forward (June issuance landing a quarter early) rather than a re-acceleration of the underlying trend: Q3'26 consensus EPS of $4.27 (+8.9% YoY) already implies a much smaller beat/gap than this quarter's actual delivered.

FY2026 EPS guidance waterfall:

Q2'26 single-quarter context (why the raise looks small):

| Step | Value | Delta | |---|---|---| | Q2 guide issued at Q1 call (low-high) | $4.15-$4.30 (mid $4.225) | — | | Q2 actual reported | $4.68 | +$0.455 (+10.8% vs. midpoint) |

FY2026 guidance table — prior vs. new vs. consensus:

| Metric | Prior Guide (Q1'26) | New Guide (Q2'26) | Consensus | vs Prior | vs Consensus | |---|---|---|---|---|---| | Adjusted diluted EPS | $16.40-$17.00 (mid $16.70) | $16.50-$17.00 (mid $16.75) | $16.90 | +$0.05 (+0.3%) | -$0.15 (-0.9%) | | Total revenue growth | ~8% (~$8.34B implied) | ~8% (~$8.34B implied, unchanged) | 7.3% ($8.28B) | Unchanged | Guide mid ~+0.7% above cons. $ | | Adjusted operating margin | 52%-53% | 52%-53% | n/a | Unchanged | n/a | | MA ARR growth | High-single-digit % | High-single-digit % | n/a | Unchanged | n/a | | Rated issuance growth | Low-single-digit % | Mid-single-digit % | n/a | Raised | n/a | | Share repurchases | $2.5B | $3.0B | n/a | +$0.5B | n/a | | Free cash flow | $2.8B-$3.0B | $2.7B-$2.9B | n/a | -$0.1B | n/a | | Restructuring charge | ~1.0% | 1.5% | n/a | +50bps, extended to YE2027 | n/a |

H2'26 implied math — the key number this quarter: H1'26 actual EPS = $4.33 + $4.68 = $9.01. FY guide mid $16.75 implies H2'26 EPS of just $7.74, +2.4% YoY vs. H2'25's $7.56 — a sharp step-down from H1's 20%+ blended growth. At the guide's low end, implied H2 EPS growth is negative. Revenue tells the same story: H1'26 actual of $4,264M against a ~7-9% full-year growth guide implies H2'26 revenue of roughly +2.4% to +6.5% YoY, again well below H1's 8-15% pace. Management's own words back this up — Q3 guided "low single-digit" revenue growth, Q4 "roughly flat."

Tone vs. Q1'26: Q1's call was conditional and hedged around April tariff volatility, with an explicit two-sided bear-case scenario. Q2's call offered no hedged bear case — "standout second quarter," "exceptional... results" — but the Street pushed back hard on the H2 revenue guide's conservatism (Manav Patnaik, Barclays: "it feels pretty conservative"). Management's defense leaned on the 2025 playbook (guided down after Liberation Day, recovered almost exactly to the original plan) rather than new caution — a second consecutive quarter of resisting extrapolating a hot print into a full-year raise.

| Metric | Q3'24 | Q4'24 | Q1'25 | Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | |---|---|---|---|---|---|---|---|---| | Revenue YoY % | +23.2% | +13.0% | +7.7% | +4.5% | +10.7% | +13.0% | +8.1% | +15.1% | | Rev accel (bps QoQ) | +155 | -1,019 | -525 | -327 | +624 | +228 | -492 | +707 | | EPS YoY % | +32.1% | +19.6% | +13.6% | +8.5% | +22.1% | +38.9% | +13.1% | +31.5% | | EPS accel (bps QoQ) | -1,051 | -1,246 | -598 | -511 | +1,358 | +1,681 | -2,588 | +1,841 |

xychart-beta
    title "MCO Revenue vs. EPS YoY Growth — 8-Quarter Trend"
    x-axis [Q3'24, Q4'24, Q1'25, Q2'25, Q3'25, Q4'25, Q1'26, Q2'26]
    y-axis "YoY Growth %" -5 --> 45
    line [23.2, 13.0, 7.7, 4.5, 10.7, 13.0, 8.1, 15.1]
    line [32.1, 19.6, 13.6, 8.5, 22.1, 38.9, 13.1, 31.5]

Top line = Revenue YoY %, second line = Adjusted EPS YoY %.

Five inflection points:

1. Q4'24 to Q2'25 — deceleration leg. Both lines roll over hard off the Q3'24 peak; revenue YoY nearly halves (23.2% to 13.0% to 7.7%) and troughs at +4.5% in Q2'25, the low point of the window.
2. Q3'25 — the turn. Revenue accelerates +624bps and EPS +1,358bps off the Q2'25 trough — the first clear reacceleration signal.
3. Q4'25 — EPS local peak (+38.9% YoY, +1,681bps accel), flattered by an easy compare against a depressed Q4'24 base; revenue growth held flat at 13.0%, not confirming an equivalent step-change.
4. Q1'26 — a pause, not a reversal. EPS growth decelerates sharply (-2,588bps) purely off the tough Q4'25 comp; revenue growth eases only modestly (13.0% to 8.1%).
5. Q2'26 — sharpest reacceleration in the window. Revenue YoY jumps +707bps to +15.1% (best print since Q3'24) and EPS jumps +1,841bps to +31.5% (second-best in the window) — both a genuine operational step-up (record issuance, margin leverage), not just an easy comp, since Q2'25's own base (+4.5%) was not depressed.

Key drivers per management commentary: MIS/ratings issuance strength, broad-based — more than $2 trillion of debt rated for a second consecutive quarter, MIS transaction revenue +34% YoY, diversified across AI/data-center financing (~20% of >$5B issuances), private credit (+40% YoY related transactions), refinancing, digital finance, and emerging markets. Operating leverage flowed straight to the bottom line — consolidated margin +440bps to 55.3%, MIS margin +410bps to 68.3%. MA held a steady recurring pace — ARR +~9% YoY to ~$3.7B, 95% trailing-12-month retention, recurring revenue now 99% of MA revenue. Management explicitly framed the beat as a pull-forward, not a trend re-rate, guiding Q3 to low-single-digit MIS revenue growth and Q4 roughly flat YoY.

| # | Catalyst | Timing | Read-through | |---|---|---|---| | 1 | Q3 2026 earnings print | Expected Oct 28, 2026 | Consensus EPS $4.27, revenue $2.080B (14 analysts); management guided Q3 MIS revenue to low-single-digit growth — a deliberate step-down after June pull-forward. | | 2 | FOMC meetings — Sept 15-16 and Oct 27-28, 2026 | Oct meeting lands the day before Q3 print | Genuinely two-sided: some forecasters model H2 cuts, but the Fed's own June dot plot leaned toward a hike. Fauber: a rate cut "could trigger some incremental opportunistic refinancing" against large maturity walls into '28. | | 3 | Hyperscaler / AI data-center debt issuance wave | Ongoing through 2H26 and into 2027 | Hyperscalers have "already exceeded" MCO's 2026 forecast and issued more debt this year than the prior three years combined; ~$800B 2026 hyperscaler capex assumption (first specific figure given). Caution: hyperscaler bond order-book coverage has softened from ~5x in February to below 2x by July. | | 4 | Private credit regulatory scrutiny (NAIC / U.S. Treasury) | Active through 2026 | Management frames retailization/regulatory modernization as a tailwind (more third-party ratings/analytics demand); a risk if NAIC's push to reduce "blind reliance on credit ratings" for insurer capital treatment gains traction. | | 5 | M&A activity reacceleration | Watch item through 2H26 | Named by management as an explicit upside lever to issuance guidance; no company or consensus M&A-volume forecast given. | | 6 | HY spreads / spec-grade default divergence | Ongoing | Spreads "still very tight by historical averages" and spec-grade default outlook declining (tailwind case), but realized private-credit default rate near a record ~6.0% and HY bond default rate ~4.0% vs. a 20-year median of 2.9% — a divergence worth monitoring. | | 7 | Tariff / geopolitical risk-off windows | Ongoing, episodic | Management flagged "headline risk" and energy-flow disruption explicitly; cited a real early-July 2026 HY risk-off window. | | 8 | New MA CEO Christina Kosmowski (5 weeks in) | Effects visible from Q3/Q4 2026 into 2027 | Early priorities: go-to-market simplification, sales-productivity, agentic-solution pricing, data-layer strengthening — framed as a multi-quarter MA ARR re-acceleration lever, no near-term guidance change. | | 9 | Restructuring program extension | Extended through YE2027, envelope +$100M | Targets $300-350M annualized savings once complete, supporting margin expansion and AI-adoption funding. | | 10 | Competitor read-through — S&P Global Q2 2026 earnings | Reported Jul 28, 2026 (6 days after MCO) | Near-term corroboration event for issuance-market strength; content not yet available as of this workspace's data-collection date. |

8 analyst questions asked on the FY2026Q2 call (Robert Fauber, CEO; Noemie Heuland, CFO); 5 well answered, 3 deflected or avoided.

| # | Analyst | Topic | Verdict | |---|---|---|---| | 1 | Manav Patnaik (Barclays) | H2 guidance conservatism | 🟢 Well answered — direct, quantified, no dodge | | 2 | Ashish Sabadra (RBC) | Issuance puts/takes, first-time-mandate upside | 🟢 Well answered — concrete list of upside levers and risks | | 3 | Toni Kaplan (Morgan Stanley) | MCP/agentic AI revenue uplift, tough comps ahead | 🔴 Deflected — qualitative color only, no dollar/ARR figure, comp question ignored | | 4 | Jeff Meuler (Baird) | "Deep currents" funding risk monitoring | 🔴 Deflected — opportunity side covered fully, explicit risk-monitoring half not engaged | | 5 | Jeff Silber (BMO) | Why data-center financing is lower-yield | 🟢 Well answered — direct mechanical explanation | | 6 | Curtis Nagle (BofA) | Is MA's ~8-9% growth sustainable? | 🟢 Well answered — balanced, cautioned against extrapolation, cited concrete supports | | 7 | Surinder Thind (Jefferies) | New MA CEO's investment/spending trajectory | 🔴 Deflected — "5 weeks in" cited to avoid committing either way | | 8 | Andrew Nicholas (William Blair) | Cheaper AI tokens — usage, efficiency, competitive risk | 🟢 Well answered — all three sub-parts covered |

Deflected in detail: (1) MCP/agentic AI revenue — no dollar or ARR-percentage quantification, comp-difficulty follow-up unaddressed; watch for a concrete MCP contribution metric in future quarters. (2) Deep-currents risk monitoring — demand side covered thoroughly, specific downside risks in private credit/infrastructure funding not named beyond one line about the recent correction being healthy. (3) MA investment trajectory under the new CEO — reasonable given five weeks' tenure, but leaves open whether MA margin guidance (34-35% FY26, mid-high 30s by 2027) could be at risk from a reinvestment push.

Macro commentary:

• Rates/inflation: a Fed rate cut with contained inflation is modeled as upside, not base case — "that could trigger some incremental opportunistic refinancing" against large maturity walls into '28 (Fauber).
• Credit spreads: HY spreads "still very tight by historical averages" with a declining spec-grade default outlook — a benign, risk-on credit backdrop; independent data shows HY OAS spread ~269bps (Jul 10, 2026) alongside a record ~6.0% private-credit default rate and ~4.0% HY bond default rate vs. a 2.9% 20-year median — tight spreads and rising realized defaults are diverging, worth monitoring.
• Issuance seasonality: 2015-2025 issuance split roughly 55/45 H1/H2; 2026 is trending toward high-50s/first-half-weighted — more front-loaded than normal, a risk framing for why H2 guidance wasn't raised alongside the issuance outlook.
• AI capex: hyperscaler capex "approach $800 billion in 2026 and grow meaningfully again in 2027"; even excluding AI/data-center activity, issuance still grew double digits YTD — a broad-based, not single-theme, credit-demand story.
• Private credit: "more than 40% growth in private credit-related transactions" and 110+ new first-time mandates this quarter; a recent private-credit "correction" is framed as healthy for underwriting discipline, alongside incoming NAIC regulatory modernization of insurers' private-asset investment frameworks.
• AI token-cost deflation: management views falling frontier-model token costs as a usage-expansion tailwind, not a pricing threat, and is skeptical of thin "AI wrapper" competitor business models generally.

Company-specific mentions:

| Company | Relationship | Read-through | |---|---|---| | Hut 8 | Customer (rated issuer) | Positive — ~$4B financing for a 350-megawatt hyperscale campus evidences continued large-scale data-center debt financing availability. | | BlackRock | Customer + cited data source | Positive — MCO rated its $2.6B tokenized money market fund (world's largest); BlackRock's $68 trillion infrastructure-funding-by-2040 estimate is a bullish multi-decade read for infrastructure financiers broadly. | | Amazon / AWS | Platform partner | Positive for AWS — another enterprise ISV (Moody's) routing spend through AWS Marketplace, deepening cloud-commit consumption. | | Microsoft | Platform partner | Positive for Microsoft — Moody's is an early AI "skill" on Microsoft 365 Copilot Cowork, supporting the Copilot-as-platform narrative (still early, 20+ engagements). | | IFC / multilateral development banks | Customer (rated issuer) | Positive for EM issuers — a second emerging-market CLO rated for IFC signals growing securitization-based capital mobilization. | | Solana (via Alphaledger) | Infrastructure partner | Positive for Solana — Moody's ratings embedded directly into tokenized fixed-income assets adds a traditional-finance credibility signal. | | NAIC (regulator) | Regulatory counterparty | Mixed/worse for insurers with heavy private-credit allocations — incoming regulatory scrutiny is a compliance-cost headwind for that cohort, though a tailwind for MCO's own ratings/analytics demand. |

Data sourced from Daloopa (company_id 490), the MCO FY2026Q2 earnings call transcript, and FMP quarterly analyst estimates for consensus.